Live Breaking News & Updates on Avacta Chief Executive Officer|Page 2

Stay updated with breaking news from Avacta chief executive officer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Avacta triggers second milestone payment in AffyXell venture

Life science company Avacta Group announced on Monday that a second milestone equity payment had been triggered, resulting in an increased shareholding for Avacta in AffyXell Therapeutics. ....

South Korea , Alastair Smith , Avacta Affimer , Avacta Group , Daewoong Pharmaceutical , Category All , Category Market Report , Category Company News , Category News And Announcements , Category Aim Bulletin , Category Tecnologia , Category Market Pulse , Category Sectorial Health Technology , Mostread Technology , Mostread Small Caps ,

Avacta : acquires Coris Bioconcept, adding a broad range of marketed professional-use rapid tests to the Group

Acquisition consistent with Avacta Diagnostics M&A strategy and complements earlier acquisition of Launch Diagnostics

Avacta Group plc , a life sciences company developing. | June 1, 2023 ....

United States , Waals Gewest , United Kingdom , Alastair Smith , Coris Bioconcept , Avacta Group , Launch Diagnostics , South America , Middle East , Quality Control , Avacta Diagnostics , Chief Executive Officer , Avacta Group Plc Stock Exchange , Press Release , Ompany Avct Gb00byyw9g87 ,

Avacta enhances rapid test portfolio with GBP7.4 million Coris buy

Avacta Group PLC on Thursday said that it has bought Coris Bioconcept SRL, adding a range of professional-use rapid tests to its product portfolio.

Avacta is a Wetherby, England-based life sciences. | June 1, 2023 ....

Alastair Smith , Coris Bioconcept , Holly Beveridge , Alliance News Ltd , Alliance News , Avacta Group , Avacta Chief Executive Officer Alastair , All Rights , Avacta Group Plc Stock Exchange , Press Release , Ife Avct Gb00byyw9g87 ,

Avacta buys Belgium-based Coris Bioconcept for £7.4m

Life science company Avacta Group announced the acquisition of Coris Bioconcept for initial cash consideration of £7.4m on Thursday. ....

United States , Waals Gewest , Alastair Smith , Avacta Group , South America , Middle East , Launch Diagnostics , Belgium Based , Mp Pound 7 4m , Category All , Category Market Report , Category Company News , Category News And Announcements , Category Aim Bulletin , Category Tecnologia , Category Market Pulse , Category Sectorial Health Technology , Mostread Technology ,

Avacta doses first patient in US tumour treatment trial

Oncology and diagnostics developer Avacta announced the dosing of the first patient in the United States under its investigational new drug (IND) application on Thursday - a milestone for its first therapeutic product ‘AVA6000’, based on its proprietary ‘preCISION’ technology. ....

United Kingdom , New York , United States , Memorial Sloan Kettering Cancer Center , Alastair Smith , Avacta Group , Category All , Category Market Report , Category Company News , Category News And Announcements , Category Aim Bulletin , Category Tecnologia , Category Market Pulse , Category Sectorial Health Technology ,